AIRLINK 172.80 Decreased By ▼ -2.93 (-1.67%)
BOP 13.27 Increased By ▲ 0.15 (1.14%)
CNERGY 7.40 Decreased By ▼ -0.14 (-1.86%)
FCCL 43.60 Decreased By ▼ -0.31 (-0.71%)
FFL 14.87 Decreased By ▼ -0.14 (-0.93%)
FLYNG 26.49 Decreased By ▼ -0.41 (-1.52%)
HUBC 129.80 Decreased By ▼ -0.43 (-0.33%)
HUMNL 13.22 Decreased By ▼ -0.12 (-0.9%)
KEL 4.45 Decreased By ▼ -0.05 (-1.11%)
KOSM 6.04 Decreased By ▼ -0.02 (-0.33%)
MLCF 55.39 Decreased By ▼ -0.64 (-1.14%)
OGDC 212.20 Decreased By ▼ -2.57 (-1.2%)
PACE 5.91 Decreased By ▼ -0.07 (-1.17%)
PAEL 41.04 Increased By ▲ 0.14 (0.34%)
PIAHCLA 16.21 Decreased By ▼ -0.11 (-0.67%)
PIBTL 9.58 Decreased By ▼ -0.17 (-1.74%)
POWER 11.52 Decreased By ▼ -0.24 (-2.04%)
PPL 178.20 Decreased By ▼ -3.28 (-1.81%)
PRL 33.49 Decreased By ▼ -0.73 (-2.13%)
PTC 22.82 Decreased By ▼ -0.24 (-1.04%)
SEARL 94.45 Decreased By ▼ -1.27 (-1.33%)
SILK 1.17 Increased By ▲ 0.03 (2.63%)
SSGC 34.94 Decreased By ▼ -0.51 (-1.44%)
SYM 15.75 No Change ▼ 0.00 (0%)
TELE 7.79 Decreased By ▼ -0.08 (-1.02%)
TPLP 10.86 Decreased By ▼ -0.12 (-1.09%)
TRG 60.90 Increased By ▲ 0.40 (0.66%)
WAVESAPP 10.69 Decreased By ▼ -0.12 (-1.11%)
WTL 1.33 Decreased By ▼ -0.02 (-1.48%)
YOUW 3.80 Increased By ▲ 0.03 (0.8%)
BR100 12,019 Decreased By -35.1 (-0.29%)
BR30 36,238 Decreased By -228.7 (-0.63%)
KSE100 113,757 Decreased By -599.4 (-0.52%)
KSE30 35,066 Decreased By -281.6 (-0.8%)
World

WHO says awaits EMA, FDA reviews of J&J COVID-19 vaccine, monitoring global data

  • U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson's COVID-19 vaccine after six women under 50 given the shot developed rare blood clots.
Published April 13, 2021 Updated April 14, 2021

GENEVA: The World Health Organization, asked about reports of rare blood clots after vaccination with the Johnson & Johnson COVID-19 shot, told Reuters on Tuesday that it awaited reviews by the U.S. and European regulators and was monitoring global data.

"We're watching closely, waiting for EMA (European Medicines Agency) and FDA (U.S. Food and Drug Administration) reviews and monitoring the global database of adverse event reports to see if there have been cases anywhere else," the WHO said in an email reply. "It will take a little time to review the data."

U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson's COVID-19 vaccine after six women under 50 given the shot developed rare blood clots.

Following the news, J&J said it was delaying the rollout of the vaccine to Europe, a week after regulators there said they were reviewing rare blood clots in four recipients of the shot in the United States.

Comments

Comments are closed.